Gotham Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.8K | Sell |
16,224
-28,781
| -64% | -$76K | ﹤0.01% | 1649 |
|
|
2025
Q1 | $135K | Buy |
+45,005
| New | +$135K | ﹤0.01% | 1494 |
|
|
2024
Q3 | – | Sell |
-14,594
| Closed | -$92.2K | – | 1471 |
|
|
2024
Q2 | $92.2K | Sell |
14,594
-17,932
| -55% | -$113K | ﹤0.01% | 1384 |
|
|
2024
Q1 | $175K | Buy |
32,526
+21,738
| +202% | +$117K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $54.2K | Buy |
+10,788
| New | +$54.2K | ﹤0.01% | 1308 |
|
|
2020
Q3 | – | Sell |
-27,855
| Closed | -$342K | – | 1083 |
|
|
2020
Q2 | $342K | Buy |
+27,855
| New | +$342K | 0.01% | 834 |
|
|
2017
Q3 | – | Sell |
-13,766
| Closed | -$104K | – | 969 |
|
|
2017
Q2 | $104K | Buy |
+13,766
| New | +$104K | ﹤0.01% | 929 |
|